盐酸氟桂利嗪治疗脑动脉硬化症的有效性与安全性观察

发布时间：2018-08-07 21:56

【摘要】：探究盐酸氟桂利嗪对于脑动脉硬化症治疗的临床疗效。选择2013年4月~2015年4月我院经临床检查确诊为脑动脉硬化症的患者108例,通过随机数表法将其分为两组,各54例。对照组采取常规疗法对患者进行治疗,观察组在此治疗基础上予以盐酸氟桂利嗪进行治疗,对两组临床治疗效果进行分析。两组治疗结束后,观察组临床治疗有效率为87.04%,对照组为64.81%,两组相比较,差异显著(P0.05);观察组治疗总满意率为87.04%明显高于对照组的70.37%,两组相比较,差异显著(P0.05);观察组不良反应发生率1.85%,对照组无不良反应,两组对比无明显差异(P0.05)。采用盐酸氟桂利嗪治疗脑动脉硬化症临床效果显著,能有效促进患者脑功能的恢复,患者满意度高,药物不良反应小,具有较高的安全性,值得推广。
[Abstract]:The clinical efficacy of Flunarizine Hydrochloride in the treatment of cerebral arteriosclerosis was investigated. 108 patients with cerebral arteriosclerosis diagnosed by clinical examination in April ~2015 in April 2013 were divided into two groups, each 54 cases. The control group was treated with conventional therapy, and the observation group was treated on the basis of the treatment. The treatment effect of flunarizine hydrochloride was analyzed in the two groups. After the two groups, the effective rate of clinical treatment in the observation group was 87.04%, the control group was 64.81% and the two groups were compared, the difference was significant (P0.05); the total satisfaction rate of the observation group was 87.04% significantly higher than that of the group 70.37%, and the difference of the two groups was significant (P0.05). The incidence of adverse reactions in the group was 1.85%. There was no adverse reaction in the control group. There was no significant difference in the comparison between the two groups (P0.05). The clinical effect of Flunarizine Hydrochloride in the treatment of cerebral arteriosclerosis was significant. It can effectively promote the recovery of the brain function, the patient's satisfaction is high, the drug adverse reaction is small, and it has high safety. It is worth popularizing.
【作者单位】：大埔县人民医院;
【分类号】：R743.1

【相似文献】